At ZS, our oncology mantra is “Cure it.” New therapeutic platforms—where advances in biology are combined with engineering methods such as designing and refining treatments—are making this goal more achievable. With these methods, one platform can help address many different types of cancer.
Our white paper explores how new insights into cancer hallmarks and advances in science and engineering are paving the way for emerging therapeutic platforms. We also share our view on where these platforms are headed
We believe the following platforms to be the fastest growing in oncology:
- Cell and gene therapy
- Tumor-agnostic development of precision medicine and immuno-oncology therapies
- Bispecific antibodies
- Antibody-drug conjugates
- Therapeutic cancer vaccines and oncolytic viruses
- Radiopharmaceuticals
Add insights to your inbox
We’ll send you content you’ll want to read – and put to use.
